| Previous Close | 32.45 |
| Open | 32.66 |
| Bid | 33.54 x 800 |
| Ask | 33.54 x 900 |
| Day's Range | 32.21 - 34.06 |
| 52 Week Range | 10.62 - 35.53 |
| Volume | 672,299 |
| Avg. Volume | 1,544,965 |
| Market Cap | 5.634B |
| Beta (5Y Monthly) | 2.13 |
| PE Ratio (TTM) | 26.47 |
| EPS (TTM) | 1.29 |
| Earnings Date | Jul. 28, 2021 - Aug. 02, 2021 |
| Forward Dividend & Yield | 1.00 (3.08%) |
| Ex-Dividend Date | May 14, 2021 |
| 1y Target Est | 35.22 |
- Zacks
Should Value Investors Buy Chemours (CC) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- Simply Wall St.
Is The Chemours Company's (NYSE:CC) 25% ROE Better Than Average?
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
- Zacks
Chemours (CC) Earnings and Revenues Beat Estimates in Q1
Chemours' (CC) Q1 results benefit from higher sales in Titanium Technologies and Advanced Performance Materials units driven by demand recovery.
© 2021 Verizon Media. All rights reserved.
